Lead Product(s): BX001
Therapeutic Area: Dermatology
Highest Development Status: Phase I Product Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable March 20, 2020
BiomX is developing BX001, its lead product candidate, to modify the appearance of acne prone skin.